Xcel Pharmaceuticals Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Employees
-
125
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$280M
Xcel Pharmaceuticals General Information
Description
Manufacturer of prescription products for the treatment of central nervous system disorders.
Contact Information
Corporate Office
- 6363 Greenwich Drive
- Suite 100
- San Diego, CA 92122
- United States
Corporate Office
- 6363 Greenwich Drive
- Suite 100
- San Diego, CA 92122
- United States
Xcel Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 01-Mar-2005 | $280M | Completed | Profitable | ||
| 3. Early Stage VC | 01-Apr-2003 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 01-Jun-2002 | $22.5M | $92.5M | Completed | Profitable | |
| 1. Early Stage VC | 01-Mar-2001 | $70M | $70M | Completed | Product Development |
Xcel Pharmaceuticals Signals
Xcel Pharmaceuticals Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Domain Associates | Venture Capital | Minority | ||
| Ferrer Freeman & Company | PE/Buyout | |||
| Greenspring Associates | Venture Capital | Minority | ||
| New Enterprise Associates | Venture Capital | Minority |
Xcel Pharmaceuticals Investments (1)
Xcel Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with Pozen (MT-300 U.S. Marketing Rights) for . The deal was made on 04-Sep-2003.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Pozen (MT-300 U.S. Marketing Rights) | 04-Sep-2003 | Corporate Asset Purchase | Buildings and Property |
Xcel Pharmaceuticals FAQs
-
When was Xcel Pharmaceuticals founded?
Xcel Pharmaceuticals was founded in 2001.
-
Where is Xcel Pharmaceuticals headquartered?
Xcel Pharmaceuticals is headquartered in San Diego, CA.
-
What is the size of Xcel Pharmaceuticals?
Xcel Pharmaceuticals has 125 total employees.
-
What industry is Xcel Pharmaceuticals in?
Xcel Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Xcel Pharmaceuticals a private or public company?
Xcel Pharmaceuticals is a Private company.
-
What is the current valuation of Xcel Pharmaceuticals?
The current valuation of Xcel Pharmaceuticals is .
-
What is Xcel Pharmaceuticals’s current revenue?
The current revenue for Xcel Pharmaceuticals is .
-
How much funding has Xcel Pharmaceuticals raised over time?
Xcel Pharmaceuticals has raised $180M.
-
Who are Xcel Pharmaceuticals’s investors?
Domain Associates, Ferrer Freeman & Company, Greenspring Associates, and New Enterprise Associates have invested in Xcel Pharmaceuticals.
-
When was Xcel Pharmaceuticals acquired?
Xcel Pharmaceuticals was acquired on 01-Mar-2005.
-
Who acquired Xcel Pharmaceuticals?
Xcel Pharmaceuticals was acquired by Bausch Health Companies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process